➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Dow
Baxter
Colorcon
Express Scripts

Last Updated: January 27, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Caprylic acid

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Caprylic acid?

Caprylic acid is an investigational drug.

There have been 5 clinical trials for Caprylic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2013.

The most common disease conditions in clinical trials are Peripheral Nervous System Diseases, Diabetic Neuropathies, and Tremor. The leading clinical trial sponsors are Accera, Inc., Celerion, and University of British Columbia.

There are three US patents protecting this investigational drug and thirty-eight international patents.

Recent Clinical Trials for Caprylic acid
TitleSponsorPhase
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral NeuropathyUniversity of British ColumbiaPhase 1/Phase 2
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionCelerionPhase 1
Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionAccera, Inc.Phase 1

See all Caprylic acid clinical trials

Clinical Trial Summary for Caprylic acid

Top disease conditions for Caprylic acid
Top clinical trial sponsors for Caprylic acid

See all Caprylic acid clinical trials

US Patents for Caprylic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Caprylic acid   Start Trial Glycolurils having functional groups and use thereof SHIKOKU CHEMICALS CORPORATION (Kagawa, JP)   Start Trial
Caprylic acid   Start Trial 1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors Janssen Pharmaceutica NV (Beerse, BE)   Start Trial
Caprylic acid   Start Trial Water temperature as a means of controlling kinetics of onsite generated peracids Ecolab USA Inc. (Saint Paul, MN)   Start Trial
Caprylic acid   Start Trial Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes APOGLYX AB (Lund, SE)   Start Trial
Caprylic acid   Start Trial Isocyanate derived organosilanes THE CHEMOURS COMPANY FC, LLC (Wilmington, DE)   Start Trial
Caprylic acid   Start Trial Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer Cocrystal Pharma, Inc. (Tucker, GA) Emory University (Atlanta, GA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Caprylic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Caprylic acid China CN105745213 2033-11-25   Start Trial
Caprylic acid China CN108164534 2033-11-25   Start Trial
Caprylic acid China CN108276412 2033-11-25   Start Trial
Caprylic acid European Patent Office EP3075735 2033-11-25   Start Trial
Caprylic acid European Patent Office EP3369735 2033-11-25   Start Trial
Caprylic acid Japan JP2015120897 2033-11-25   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Dow
Baxter
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.